All AbMole products are for research use only, cannot be used for human consumption.
Bms-536924 is an orally active, competitive and selective insulin-like growth factor receptor (IGF-1R) kinase and insulin receptor (IR) inhibitor with IC50 of 100 nM and 73 nM, respectively. It also showed moderate inhibitory activity against Mek, Fak and Lck, but almost no inhibitory activity against Akt1 and MAPK1/2.
 |
Source | Onco Targets Ther (2015). Figure 1. BMS-536924 |
| Method | cell viability assay | |
| Cell Lines | TMZ-resistant cells | |
| Concentrations | 400 nM | |
| Incubation Time | 24, 48, or 72 h | |
| Results | BMS-536924 also significantly reduced the viability of both TMZ-sensitive and -resistant lines, in a time-dependent manner |
| Cell Experiment | |
|---|---|
| Cell lines | TGBC-1TKB, TGBC-2TKB and TGBC-14TKB cell lines |
| Preparation method | In vitro cell growth. Four thousand cells were seeded into a 96-well plate and each was treated with several concentrations of BMS-536924. Cell growth was measured using WST-1 reagent (Roche, Basel, Switzerland), as described previously. |
| Concentrations | 0, 1, 5, 10μM |
| Incubation time | 0, 1, 2, 3, 4 days |
| Animal Experiment | |
|---|---|
| Animal models | TGBC-1TKB tumour xenograft in nude mice |
| Formulation | a mixture of polyethylene glycol 400 (PEG400 ⁄ water, 4:1 vol ⁄ vol) |
| Dosages | 70 mg ⁄ kg once daily for 2 weeks |
| Administration | oral gavage |
| Molecular Weight | 479.96 |
| Formula | C25H26ClN5O3 |
| CAS Number | 468740-43-4 |
| Solubility (25°C) | DMSO 66 mg/mL |
| Storage |
Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month |
| Related IGF-1R Products |
|---|
| Indirubin Derivative E804
Indirubin Derivative E804 is a potent inhibitor of Insulin-like Growth Factor 1 Receptor (IGF1R), with an IC50 of 0.65 μM for IGF1R. |
| IGF-I (24-41)
IGF-I (24-41) (Insulin-like Growth Factor I (24-41)) is amino acids 24 to 41 fragment of IGF-I. |
| GIP, human
GIP, human is a peptide hormone consisting of 42 amino acids that also acts as a promoter of glucose-dependent insulin secretion and a weak inhibitor of gastric acid secretion. In addition, GIP, human acts as an enteric proinsulin hormone released by intestinal K cells in response to nutrient intake. |
| VMB-100
VMB-100 is an engineered mRNA molecule encoding human insulin-like growth factor-1 (IGF-1) that induces IGF-1 expression in human muscle cells. |
| NBI-31772 hydrate
NBI-31772 hydrate is a potent inhibitor of interaction between insulin-like growth factor (IGF) and IGF-binding proteins (IGFBPs). NBI-31772 hydrate is also a nonpeptide ligand that releases bioactive IGF-I from the IGF-I/IGFBP-3 complex (Kis=1-24 nM for all six human subtypes). Anxiolytic and antidepressant-like effects. |
All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
